| Identification | |
| Name: | Phenol,2-[(1R)-3-[bis(1-methylethyl)amino]-1-phenylpropyl]-4-methyl- |
| Synonyms: | Phenol,2-[3-[bis(1-methylethyl)amino]-1-phenylpropyl]-4-methyl-, (R)-;(+)-Tolterodine;(R)-(+)-N,N-Diisopropyl-3-(2-hydroxy-5-methylphenyl)-3-phenylpropylamine;(R)-(+)-Tolterodine;(R)-N,N-Diisopropyl-3-(2-hydroxy-5-methylphenyl)-3-phenylpropanamine;(R)-N,N-Diisopropyl-N-[3-(2-hydroxy-5-methylphenyl)-3-phenylpropyl]amine;(R)-Tolterodine;Kabi 2234;PNU 200583; |
| CAS: | 124937-51-5 |
| Molecular Formula: | C22H31NO |
| Molecular Weight: | 325.49 |
| InChI: | InChI=1/C22H31NO/c1-16(2)23(17(3)4)14-13-20(19-9-7-6-8-10-19)21-15-18(5)11-12-22(21)24/h6-12,15-17,20,24H,13-14H2,1-5H3/t20-/m0/s1 |
| Molecular Structure: | ![(C22H31NO) Phenol,2-[3-[bis(1-methylethyl)amino]-1-phenylpropyl]-4-methyl-, (R)-;(+)-Tolterodine;(R)-(+)-N,N-Di...](https://img.guidechem.com/casimg/124937-51-5.gif) |
| Properties | |
| Density: | 1.003 g/cm3 |
| Appearance: | white like or light brown crystalline powder |
| Usage: | A muscarinic receptor antagonist. Used in the treatment of urinary incontinence. |
| Safety Data | |
 |
|
